Merck (NYSE:MRK) led a $15 million Series B round for Medivo and its health data analytics platform.
Medivo
Piper Jaffray: Abiomed wins reimbursement code | Wall Street Beat
Abiomed (NSDQ:ABMD) is slated to win a reimbursement code for procedures involving its Impella heart pump, according to analysts at Piper Jaffray.
In a summary of recent editorial panel decisions, the American Medical Assn. revealed that the panel approved the Society for Cardiovascular Angiography and Interventions’ proposal for the reimbursement code, according to theflyonthewall.com.
Safeguard leads $7 M funding round for Medivo | Funding Roundup
Safeguard Scientifics (NYSE:SFE) led a $7 million Series A financing round for health care IT company Medivo that provides data analytics and lab testing services.